Literature DB >> 7174787

Alternative complement pathway activation increases mortality in a model of burn injury in mice.

J A Gelfand, M Donelan, A Hawiger, J F Burke.   

Abstract

We have studied the role of the complement system in burn injury in an experimental model in mice. A 25% body surface area, full-thickness scald wound was produced in anesthetized animals. Massive activation of the alternative complement pathway, but not the classical pathway, was seen. This activation was associated with the generation of neutrophil aggregating activity in the plasma, neutrophil aggregates in the lungs, increased pulmonary vascular permeability, and increased lung edema formation. Decomplementation with cobra venom factor (CVF) or genetic C5 deficiency diminished these pathologic changes, and CVF pretreatment substantially reduced burn mortality in the first 24 h. Preliminary data show that human burn patients have a similar pattern of complement activation involving predominantly the alternative pathway, indicating the possible relevance of the murine model to human disease.

Entities:  

Mesh:

Year:  1982        PMID: 7174787      PMCID: PMC370333          DOI: 10.1172/jci110715

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Serum protein profiles in thermal burns. II. Protease inhibitors, complement factors, and c-reactive protein.

Authors:  J C Daniels; D L Larson; S Abston; S E Ritzmann
Journal:  J Trauma       Date:  1974-02

2.  Study of lymphocyte depletion and serum complement perturbations following acute burn trauma.

Authors:  M F Farrell; N K Day; V Tsakraklides; R A Good; S B Day
Journal:  Surgery       Date:  1973-05       Impact factor: 3.982

3.  Dual pathways of complement interaction with guinea pig immunoglobulins.

Authors:  A L Sandberg; A G Osler
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

4.  Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B.

Authors:  P R Craddock; J G White; H S Jacob
Journal:  J Lab Clin Med       Date:  1978-03

5.  Development and characterization of a hemolytic assay for mouse C4.

Authors:  J P Atkinson; K McGinnis; D Shreffler
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Alterations of complement system following thermal injury: use in estimation of vital prognosis.

Authors:  Ch Dhennin; G Pinon; J M Greco
Journal:  J Trauma       Date:  1978-02

Review 7.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

Authors:  H S Jacob; P R Craddock; D E Hammerschmidt; C F Moldow
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

8.  Serum complement levels in bacteremia due to gram-negative organisms.

Authors:  W R McCabe
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

9.  A sensitive microassay for the murine alternative complement pathway.

Authors:  K A Joiner; R Shahon; J A Gelfand
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

10.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

View more
  8 in total

1.  Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.

Authors:  J W Larrick; J Wang; B M Fendly; D E Chenoweth; S L Kunkel; T Deinhart
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

2.  Preferential activation and depletion of the alternative complement pathway by burn injury.

Authors:  J A Gelfand; M Donelan; J F Burke
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

3.  Suppression of in vitro lymphocyte and neutrophil responses by a low molecular weight suppressor active peptide from burn-patient sera.

Authors:  A N Ozkan; J L Ninnemann
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

4.  Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.

Authors:  J H Stevens; P O'Hanley; J M Shapiro; F G Mihm; P S Satoh; J A Collins; T A Raffin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 5.  Interleukin-1 and the response to injury.

Authors:  E Kaplan; C A Dinarello; J A Gelfand
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia.

Authors:  Felipe E Pedroso; Paul B Spalding; Michael C Cheung; Relin Yang; Juan C Gutierrez; Andrea Bonetto; Rui Zhan; Ho Lam Chan; Nicholas Namias; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-03-29       Impact factor: 12.910

Review 7.  Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis.

Authors:  Marco Mannes; Christoph Q Schmidt; Bo Nilsson; Kristina N Ekdahl; Markus Huber-Lang
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

Review 8.  Therapeutic uses of recombinant complement protein inhibitors.

Authors:  K R Kalli; P Hsu; D T Fearon
Journal:  Springer Semin Immunopathol       Date:  1994
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.